Thermo Fisher Scientific Inc. Stock
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
611.24 USD | -0.41% | -0.17% | +14.98% |
02:44pm | Leerink Partners Adjusts Thermo Fisher Scientific Price Target to $645 From $600 | MT |
12:14pm | RBC Raises Price Target on Thermo Fisher Scientific to $767 From $664, Keeps Outperform Rating | MT |
Capitalization | 235B 319B | P/E ratio 2024 * |
38.2x | P/E ratio 2025 * | 33.4x |
---|---|---|---|---|---|
Enterprise value | 232B 315B | EV / Sales 2024 * |
6.03x | EV / Sales 2025 * | 5.56x |
Free-Float |
86.05% | Yield 2024 * |
0.24% | Yield 2025 * | 0.26% |
Last Transcript: Thermo Fisher Scientific Inc.
1 day | -0.02% | ||
1 week | +1.20% | ||
Current month | -0.15% | ||
1 month | +2.52% | ||
3 months | +6.68% | ||
6 months | +2.83% | ||
Current year | +15.71% |
Director | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Director of Finance/CFO | 57 | 01-05-31 | |
Sebastian Pacios
CTO | Chief Tech/Sci/R&D Officer | - | 23-09-30 |
Manager | Title | Age | Since |
---|---|---|---|
Scott Sperling
BRD | Director/Board Member | 66 | 06-11-08 |
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Tyler Jacks
BRD | Director/Board Member | 63 | 09-05-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
11.69% | 2 M€ | -25.75% | ||
7.43% | 18 M€ | +9.57% | - | |
5.37% | 2 M€ | -.--% |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-0.70% | +1.20% | +20.19% | +7.38% | 235B | ||
+0.19% | +2.94% | +9.73% | -17.42% | 197B | ||
+0.63% | +3.63% | +63.82% | +44.80% | 176B | ||
+1.07% | +3.02% | +56.93% | +88.55% | 123B | ||
+0.22% | -0.91% | +11.91% | -9.90% | 61.56B | ||
-0.18% | +3.20% | -7.14% | -43.64% | 41.04B | ||
-3.29% | -7.10% | -13.09% | -30.02% | 39.44B | ||
-1.67% | -1.42% | +20.93% | -23.04% | 39.19B | ||
+0.31% | +0.19% | +33.73% | - | 39.94B | ||
-0.87% | +2.42% | +68.30% | -15.18% | 36.84B | ||
Average | -0.60% | +0.94% | +26.53% | +0.17% | 98.84B | |
Weighted average by Cap. | -0.06% | +1.79% | +29.84% | +12.71% |
2024 * | 2025 * | |
---|---|---|
Net sales | 42.93B 58.3B | 45.67B 62.02B |
Net income | 6.14B 8.34B | 6.93B 9.4B |
Net Debt | 24.16B 32.81B | 19.33B 26.25B |
Date | Price | Change | Volume |
---|---|---|---|
24-09-13 | 610.30 $ | -0.56% | 530,675 |
24-09-12 | 614.16 $ | -0.70% | 1,397,629 |
24-09-11 | 618.46 $ | -0.92% | 1,324,098 |
24-09-10 | 624.21 $ | +0.61% | 1,302,892 |
24-09-09 | 620.42 $ | +1.49% | 1,443,321 |
Delayed Quote Nyse, September 12, 2024 at 04:00 pm
More quotes- Stock Market
- Equities
- TMO Stock
MarketScreener is also available in this country: United States.
Switch edition